Mylan board survives ouster attempt, but shareholders reject rich pay packages
The vote followed a vociferous effort by several pension funds that argued Mylan directors destroyed shareholder value in the wake of the EpiPen scandal.
Mylan stockholders voted to reelect its board at the annual meeting on Thursday, rebuffing an unusual and highly public campaign from some top shareholders determined to oust many of the directors, including the chief executive officer.
But the company also suffered a rebuke as its shareholders voted against a measure to approve executive compensation. That vote doesn’t force Mylan to reduce its pay packages, but most companies do try to
